| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1097/QAD.0B013E3283543E2C |
| P698 | PubMed publication ID | 22874478 |
| P50 | author | Nathan Ford | Q87771393 |
| P2093 | author name string | Teri Roberts | |
| Alexandra Calmy | |||
| P433 | issue | 13 | |
| P921 | main subject | viral load | Q2528140 |
| P304 | page(s) | 1719-1720 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Viral load monitoring in resource-limited settings: a medical and public health priority | |
| P478 | volume | 26 |
| Q42258902 | After first-line ART: towards an evidence-based SECOND-LINE. |
| Q38944299 | Association between self-reported adherence and HIV viral load suppression among older children and adolescents |
| Q34210416 | Can we stop AIDS with antiretroviral-based treatment as prevention? |
| Q35112701 | Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients |
| Q26860854 | Developments in CD4 and viral load monitoring in resource-limited settings |
| Q38988871 | Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring |
| Q37625173 | Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting |
| Q37732266 | First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting |
| Q38169292 | Getting to zero HIV deaths: progress, challenges and ways forward |
| Q33647567 | Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study |
| Q99636412 | Point-of-care viral load testing among adolescents and youth living with HIV in Haiti: a protocol for a randomised trial to evaluate implementation and effect |
| Q36181713 | Priorities for developing countries in the global response to non-communicable diseases |
| Q33589766 | Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa |
| Q34775595 | Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti |
| Q30390065 | The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it? |
Search more.